X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3428) 3428
Publication (210) 210
Newsletter (118) 118
Book Review (55) 55
Newspaper Article (25) 25
Conference Proceeding (16) 16
Magazine Article (16) 16
Book Chapter (11) 11
Dissertation (9) 9
Trade Publication Article (5) 5
Book / eBook (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
formoterol (2135) 2135
humans (2116) 2116
formoterol fumarate (1464) 1464
asthma (1418) 1418
male (1265) 1265
respiratory system (1153) 1153
female (1144) 1144
index medicus (1142) 1142
asthma - drug therapy (1085) 1085
administration, inhalation (980) 980
salmeterol (975) 975
middle aged (903) 903
adult (883) 883
bronchodilator agents - administration & dosage (807) 807
ethanolamines - administration & dosage (800) 800
budesonide (733) 733
bronchodilator agents - therapeutic use (660) 660
ethanolamines - therapeutic use (644) 644
aged (637) 637
pulmonary disease, chronic obstructive - drug therapy (632) 632
treatment outcome (610) 610
double-blind method (591) 591
pharmacology & pharmacy (583) 583
drug therapy, combination (541) 541
copd (491) 491
drug combinations (480) 480
albuterol - analogs & derivatives (470) 470
drug therapy (466) 466
salmeterol xinafoate (432) 432
adolescent (418) 418
obstructive pulmonary-disease (402) 402
salbutamol (400) 400
budesonide - administration & dosage (381) 381
efficacy (377) 377
lung diseases, obstructive (373) 373
chronic obstructive pulmonary disease (371) 371
adrenergic beta-agonists - therapeutic use (364) 364
albuterol - therapeutic use (363) 363
exacerbations (351) 351
ethanolamines - pharmacology (334) 334
asthma - physiopathology (327) 327
albuterol - administration & dosage (325) 325
bronchodilator agents - adverse effects (317) 317
corticosteroids (316) 316
fluticasone (313) 313
adrenergic beta-agonists - administration & dosage (312) 312
dose-response relationship, drug (310) 310
medicine, general & internal (300) 300
ethanolamines - adverse effects (296) 296
safety (294) 294
child (291) 291
pulmonary disease, chronic obstructive - physiopathology (289) 289
cross-over studies (288) 288
allergy (287) 287
tiotropium (286) 286
budesonide/formoterol (285) 285
inhaled corticosteroids (282) 282
time factors (282) 282
budesonide - therapeutic use (273) 273
animals (270) 270
nebulizers and vaporizers (266) 266
forced expiratory volume - drug effects (263) 263
anti-asthmatic agents - administration & dosage (259) 259
forced expiratory volume (255) 255
fluticasone propionate (248) 248
dosage and administration (247) 247
therapy (244) 244
double-blind (241) 241
adrenal cortex hormones - administration & dosage (240) 240
care and treatment (235) 235
anti-asthmatic agents - therapeutic use (231) 231
immunology (228) 228
research (226) 226
cardiac & cardiovascular systems (225) 225
pulmonary and respiratory medicine (219) 219
respiratory tract diseases (216) 216
adrenergic beta-2 receptor agonists - administration & dosage (214) 214
quality of life (210) 210
pulmonary/respiratory (207) 207
randomized controlled trials as topic (207) 207
adrenergic beta-agonists - pharmacology (206) 206
drug administration schedule (203) 203
combination (200) 200
bronchodilator agents - pharmacology (197) 197
analysis (193) 193
clinical trials (189) 189
single inhaler (189) 189
adrenal cortex hormones - therapeutic use (188) 188
metered dose inhalers (185) 185
albuterol (184) 184
severity of illness index (182) 182
respiratory function tests (180) 180
management (171) 171
aged, 80 and over (170) 170
children (169) 169
steroids (169) 169
young adult (164) 164
adrenergic beta-agonists - adverse effects (161) 161
antiasthmatic agents (161) 161
combination therapy (161) 161
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3374) 3374
German (83) 83
Spanish (38) 38
French (29) 29
Japanese (20) 20
Russian (17) 17
Polish (14) 14
Portuguese (10) 10
Chinese (9) 9
Italian (9) 9
Czech (7) 7
Danish (5) 5
Turkish (4) 4
Romanian (2) 2
Hungarian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 20, pp. 1865 - 1876
Journal Article
Drugs, ISSN 0012-6667, 2008, Volume 68, Issue 14, pp. 1975 - 2000
Journal Article
Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, ISSN 1098-3015, 10/2017, Volume 20, Issue 9, p. A889
Journal Article
Respirology, ISSN 1323-7799, 11/2019, Volume 24, Issue S2, pp. 197 - 197
Journal Article
Respirology, ISSN 1323-7799, 11/2019, Volume 24, Issue S2, pp. 199 - 200
Journal Article
Respirology, ISSN 1323-7799, 11/2019, Volume 24, Issue S2, pp. 63 - 63
Journal Article
Respirology, ISSN 1323-7799, 11/2019, Volume 24, Issue S2, pp. 196 - 196
Journal Article
EUROPEAN RESPIRATORY JOURNAL, ISSN 0903-1936, 04/2019, Volume 53, Issue 4
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 20, pp. 1877 - 1887
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 10/2009, Volume 180, Issue 8, pp. 741 - 750
Journal Article
BMC Pulmonary Medicine, ISSN 1471-2466, 2018, Volume 18, Issue 1, pp. 107 - 14
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2017, Volume 126, pp. 105 - 115
Abstract Background The long-term safety and efficacy of a novel Co-Suspension™ Delivery Technology glycopyrrolate (GP)/formoterol fumarate (FF) 18/9.6 μg... 
Pulmonary/Respiratory | Muscarinic antagonists | Co-Suspension™ Delivery Technology | Metered dose inhaler | β2-agonist | COPD | agonist | INDACATEROL | TWICE-DAILY FORMOTEROL | PLACEBO | CARDIAC & CARDIOVASCULAR SYSTEMS | QVA149 | COMBINATION | ONCE-DAILY TIOTROPIUM | Co-Suspension (TM) Delivery Technology | THERAPY | RESPIRATORY SYSTEM | GLYCOPYRRONIUM | beta-agonist | COPD PATIENTS | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Male | Muscarinic Antagonists - therapeutic use | Tiotropium Bromide - administration & dosage | Metered Dose Inhalers - utilization | Adrenergic beta-2 Receptor Agonists - therapeutic use | Female | Drug Therapy, Combination | Glycopyrrolate - adverse effects | Severity of Illness Index | Formoterol Fumarate - pharmacology | Drug Tolerance | Formoterol Fumarate - adverse effects | Administration, Inhalation | Treatment Outcome | Tiotropium Bromide - pharmacology | Muscarinic Antagonists - administration & dosage | Glycopyrrolate - administration & dosage | Smoking - epidemiology | Adrenergic beta-2 Receptor Agonists - administration & dosage | Dyspnea - drug therapy | Glycopyrrolate - pharmacology | Aged | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Medicine, Experimental | Medical research | Medical colleges | Formoterol | Lung diseases, Obstructive | Care and treatment | Respiratory therapy | Drugs | Drug delivery systems | Effectiveness | Statistical analysis | Lung diseases | Clinical trials | Glycopyrrolate | Long term | Side effects | Randomization | Dyspnea | Technology | Obstructive lung disease | Chronic obstructive pulmonary disease | Safety | Drug therapy | Respiration
Journal Article
Respiratory Medicine, ISSN 0954-6111, 08/2017, Volume 129, pp. 179 - 188
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 9, pp. 850 - 860
Journal Article
Journal Article
Journal Article